These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17109975)

  • 21. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T; Shinomura M; Yokokawa K; Kuze I; Konishi A; Kawaji K; Kodama EN; Hata K; Takahashi S; Nirasawa S; Sakuda S; Yasukawa K
    J Nat Med; 2015 Jul; 69(3):432-40. PubMed ID: 25663480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, and in vitro enzymatic and antiviral evaluation of d4T polyphosphate derivatives as chain terminators.
    Yang S; Pannecouque C; Herdewijn P
    Chem Biodivers; 2012 Oct; 9(10):2186-94. PubMed ID: 23081918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
    Zhao C; Weber S; Schols D; Balzarini J; Meier C
    Angew Chem Int Ed Engl; 2020 Dec; 59(49):22063-22071. PubMed ID: 32379948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.
    Lennerstrand J; Stammers DK; Larder BA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2144-6. PubMed ID: 11408240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.
    Smith RA; Raugi DN; Wu VH; Leong SS; Parker KM; Oakes MK; Sow PS; Ba S; Seydi M; Gottlieb GS;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7437-46. PubMed ID: 26392486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V; Larder BA
    Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase.
    Gavriliu D; Fossey C; Ciurea A; Delbederi Z; Sugeac E; Ladurée D; Schmidt S; Laumond G; Aubertin AM
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(8-9):505-33. PubMed ID: 12484448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4'-Ethynylstavudine (4'-Ed4T) has potent anti-HIV-1 activity with reduced toxicity and shows a unique activity profile against drug-resistant mutants.
    Tanaka H; Haraguchi K; Kumamoto H; Baba M; Cheng YC
    Antivir Chem Chemother; 2005; 16(4):217-21. PubMed ID: 16130520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design.
    Kukhanova M; Li X; Chen SH; King I; Doyle T; Prusoff W; Cheng YC
    Mol Pharmacol; 1998 May; 53(5):801-7. PubMed ID: 9584205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
    Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
    Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
    Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
    Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide.
    Herschhorn A; Oz-Gleenberg I; Hizi A
    Biochemistry; 2008 Jan; 47(1):490-502. PubMed ID: 18052256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing D- and L-thymidine 5'-triphosphate as substrate.
    Focher F; Maga G; Bendiscioli A; Capobianco M; Colonna F; Garbesi A; Spadari S
    Nucleic Acids Res; 1995 Aug; 23(15):2840-7. PubMed ID: 7544886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
    Uckun FM
    Arzneimittelforschung; 2006 Feb; 56(2A):121-35. PubMed ID: 16570821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase.
    Meyer P; Schneider B; Sarfati S; Deville-Bonne D; Guerreiro C; Boretto J; Janin J; Véron M; Canard B
    EMBO J; 2000 Jul; 19(14):3520-9. PubMed ID: 10899107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective action of 2',3'-didehydro-2',3'-dideoxythymidine triphosphate on human immunodeficiency virus reverse transcriptase and human DNA polymerases.
    Huang P; Farquhar D; Plunkett W
    J Biol Chem; 1992 Feb; 267(4):2817-22. PubMed ID: 1370834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine.
    Haraguchi K; Takeda S; Tanaka H; Nitanda T; Baba M; Dutschman GE; Cheng YC
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3775-7. PubMed ID: 14552777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.